Oxford Biomedica Appoints Laurence Espinasse as Non-Executive Director
Oxford, UK – 25 July 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, “OXB” or “the Company”), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Laurence…